AST 1306 tosylate
- Catalog NO.：A896079
- CAS No. : 1050500-29-2
- Molecular Formula：C31H26ClFN4O5S
- Molecular Weight： 621.08
1. Please click the
to confirm the discount and stock quantity.2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Product Details
| CAS Number | 1050500-29-2 | Appearance | |
| Catalog Number | A896079 | MDL Number | MFCD17215204 |
| Molecular Formula | C31H26ClFN4O5S | Molecular Weight | 621.08 |
| Boiling Point | Melting Point | ||
| Flash Point | Density | ||
| Synonyms | N-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)acrylamide 4-methylbenzenesulfonate;AST-1306 p-Toluenesulfonic Acid | ||
| Storage Condition | Store in a tightly closed container,in a cool and dry place | ||
Safety
| GHS Pictogram |
|
||
| Signal Word | Warning | UN Number | |
| Hazard Statements | H302-H315-H319-H335 | Class | |
| Precautionary Statements | P261-P305+P351+P338 | Packing Group | |
Description
|
Allitinib, also known as AST1306 and ALS 1306, is a potent, selective, irreversible ErbB2 and EGFR inhibitor. AST-1306 inhibits the enzymatic activities of wild-type epidermal growth factor receptor (EGFR) and ErbB2 as well as EGFR resistant mutant in both cell-free and cell-based systems. AST1306 was found to function as an irreversible inhibitor, most likely through covalent interaction with Cys797 and Cys805 in the catalytic domains of EGFR and ErbB2, respectively. In vivo, AST1306 potently suppressed tumor growth in ErbB2-overexpressing adenocarcinoma xenograft and FVB-2/N(neu) transgenic breast cancer mouse models, but weakly inhibited the growth of EGFR-overexpressing tumor xenografts. |
